IRIS
DI MARTINO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.400
AS - Asia 1.026
EU - Europa 834
SA - Sud America 156
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 53
OC - Oceania 8
Totale 3.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.341
IT - Italia 453
SG - Singapore 392
CN - Cina 173
IN - India 123
BR - Brasile 118
GB - Regno Unito 93
DE - Germania 91
VN - Vietnam 69
BD - Bangladesh 46
HK - Hong Kong 42
FI - Finlandia 41
CA - Canada 35
NL - Olanda 29
ID - Indonesia 26
PK - Pakistan 25
JO - Giordania 23
SE - Svezia 22
SA - Arabia Saudita 20
ZA - Sudafrica 15
MX - Messico 14
ES - Italia 13
FR - Francia 13
EG - Egitto 12
IQ - Iraq 12
CO - Colombia 11
UA - Ucraina 11
AR - Argentina 9
JP - Giappone 9
MY - Malesia 9
RU - Federazione Russa 9
TR - Turchia 9
CZ - Repubblica Ceca 8
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
IR - Iran 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PT - Portogallo 7
KE - Kenya 6
PL - Polonia 6
AT - Austria 5
ET - Etiopia 5
KR - Corea 5
LB - Libano 5
RO - Romania 5
CY - Cipro 4
EC - Ecuador 4
GT - Guatemala 4
UZ - Uzbekistan 4
BG - Bulgaria 3
CH - Svizzera 3
MA - Marocco 3
PH - Filippine 3
VE - Venezuela 3
AL - Albania 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
PS - Palestinian Territory 2
SC - Seychelles 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BO - Bolivia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.479
Salva come PNG Salva come JPEG
Città #
San Jose 257
Singapore 196
Ashburn 164
Chandler 110
Dallas 73
Santa Clara 68
Munich 63
Bengaluru 47
Hefei 46
Chicago 45
London 44
Council Bluffs 42
Beijing 37
Hong Kong 32
Milan 31
Turku 29
New York 26
Los Angeles 25
Lawrence 24
Princeton 24
Ho Chi Minh City 23
Rome 21
Catanzaro 18
Hanoi 16
Amman 15
Naples 15
Boardman 14
Jeddah 14
Carbonia 12
Helsinki 12
Parma 12
San Nicola Manfredi 12
São Paulo 12
San Francisco 11
Montreal 10
Spezzano della Sila 10
Atlanta 9
Chennai 9
Palermo 9
Wilmington 9
Bologna 8
Buffalo 8
Catania 8
Delhi 8
Frankfurt am Main 8
Irbid 8
Madrid 8
Cosenza 7
Des Moines 7
Kaunas 7
Ottawa 7
Tokyo 7
Afragola 6
Da Nang 6
Ercolano 6
Hyderabad 6
Kuala Lumpur 6
Riyadh 6
Santo Stefano di Rogliano 6
Sezze 6
Ahmedabad 5
Brooklyn 5
Cape Town 5
Cardiff 5
Dublin 5
Haiphong 5
Kyiv 5
Lucknow 5
Melito di Porto Salvo 5
Meppel 5
Nairobi 5
Olomouc 5
Orem 5
Pune 5
Sacramento 5
Seattle 5
Warsaw 5
Addis Ababa 4
Biên Hòa 4
Boston 4
Dhaka 4
Glasgow 4
Hanover 4
Islamabad 4
Istanbul 4
Johannesburg 4
Lima 4
Manchester 4
Melbourne 4
Nicosia 4
Oristano 4
Perugia 4
Redmond 4
Stockholm 4
Tanta 4
Tashkent 4
The Dalles 4
Toronto 4
Tubarão 4
West Jordan 4
Totale 1.962
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 497
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 146
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 119
Augmented reality (AR) in minimally invasive surgery (MIS) training: where are we now in Italy? The Italian Society of Endoscopic Surgery (SICE) ARMIS survey 119
miR-22 suppresses DNA ligase III addiction in multiple myeloma 108
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 102
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 98
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer 89
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 82
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 82
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 79
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 79
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 77
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 76
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 75
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 75
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 74
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 74
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 71
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 69
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 68
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 67
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 65
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells 65
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 61
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 60
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 60
In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells (CO-FIRST AUTHOR) 59
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 57
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 57
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: In vitro and in vivo anti-tumor activity 55
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 52
Mmrf-commpass data integration and analysis for identifying prognostic markers 52
Ethical Perspectives on Pharmacogenomic Profiling 51
An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery 51
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 49
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 47
LNA-i-miR-221 activity in colorectal cancer: A reverse translational investigation 46
A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer 43
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure-based virtual screening 43
null 43
The EASY-NET research programme: background, structure, and methodology 39
Current status of liver surgery for non-colorectal non-neuroendocrine liver metastases: the NON.LI.MET. Italian Society for Endoscopic Surgery and New Technologies (SICE) and Association of Italian Surgeons in Europe (ACIE) collaborative international survey 38
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 37
The potential role of miRNAs in multiple myeloma therapy 35
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 31
null 31
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 14
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 12
Discovery of new MicroRNAs and their mRNA targets in patients with acute ischemic stroke 8
null 4
Totale 3.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022123 0 0 0 22 5 0 4 21 34 15 17 5
2022/2023394 55 25 28 13 45 26 6 25 49 40 55 27
2023/2024476 90 33 42 39 45 71 25 41 10 18 27 35
2024/2025876 75 20 27 37 64 119 64 55 55 21 142 197
2025/20261.536 108 154 126 149 168 80 211 74 157 147 96 66
2026/202787 30 57 0 0 0 0 0 0 0 0 0 0
Totale 3.591